RT Journal Article
SR Electronic
T1 Differentiation of Fungal, Viral, and Bacterial Sepsis using Multimodal Deep Learning
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.10.23288378
DO 10.1101/2023.04.10.23288378
A1 Boussina, Aaron
A1 Ramesh, Karthik
A1 Arora, Himanshu
A1 Ratadiya, Pratik
A1 Nemati, Shamim
YR 2023
UL http://medrxiv.org/content/early/2023/04/11/2023.04.10.23288378.abstract
AB Sepsis is a major cause of morbidity and mortality worldwide, and is caused by bacterial infection in a majority of cases. However, fungal sepsis often carries a higher mortality rate both due to its prevalence in immunocompromised patients as well as delayed recognition. Using chest x-rays, associated radiology reports, and structured patient data from the MIMIC-IV clinical dataset, the authors present a machine learning methodology to differentiate between bacterial, fungal, and viral sepsis. Model performance shows AUCs of 0.81, 0.83, 0.79 for detecting bacterial, fungal, and viral sepsis respectively, with best performance achieved using embeddings from image reports and structured clinical data. By improving early detection of an often missed causative septic agent, predictive models could facilitate earlier treatment of non-bacterial sepsis with resultant associated mortality reduction.Competing Interest StatementS.N. is co-founder of a UCSD start-up, Healcisio Inc., which is focused on commercialization of advanced analytical decision support tools. Funding StatementS.N. is funded by the National Institutes of Health (R35GM143121). Mr. Boussina is funded by the National Library of Medicine (#2T15LM011271-11). The opinions or assertions contained herein are the private ones of the author and are not to be construed as official or reflecting the views of the NIH or any other agency of the US Government. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All source data used in this study is openly available via MIMIC IV: https://physionet.org/content/mimiciv/2.0/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors